National academy

NTHU Researchers Develop Ultrasonic Vortex Thrombolytic Device

Friday, September 24, 2021 - 10:00am

Working with industrial partners, Yehs team has developed a 0.2-mm ultrasonic device, which can generate tornado-like ultrasonic vortex and create a strong turbulent around the thrombus, therefore increasing penetration of thrombolytic drugs and resulting in very effective thrombolysis.

Key Points: 
  • Working with industrial partners, Yehs team has developed a 0.2-mm ultrasonic device, which can generate tornado-like ultrasonic vortex and create a strong turbulent around the thrombus, therefore increasing penetration of thrombolytic drugs and resulting in very effective thrombolysis.
  • Yeh said that animal studies have shown results of 60% thrombus shrinkage in the mice brain after applying ultrasonic vortex for ten minutes, demonstrating the potential of fast treatment.
  • Yeh added that his team is also working on using ultrasonic vortex for noninvasive thrombolysis, which provides potential to treat embolisms in the brain.
  • Reflecting on how he first got interested in ultrasonic vortex, Yeh recalled that it was a family trip to a marine science museum ten years ago.

Fitness Superstar, Tunde Oyeneyin, Joins Expert Lineup of Speakers for Award-Winning Optima Conference

Thursday, September 23, 2021 - 7:54pm

The keynote address will take place at 9:45 a.m. Mountain Standard Time the first day of the conference, Thursday, October 21.

Key Points: 
  • The keynote address will take place at 9:45 a.m. Mountain Standard Time the first day of the conference, Thursday, October 21.
  • Oyeneyin is a popular instructor on Pelotons interactive fitness platform, where she regularly leads 20,000 live riders through her motivational online classes.
  • We are thrilled to have Tunde joining us at Optima," said Laurie McCartney, President of Ascend Learnings Fitness and Wellness brands, including NASM.
  • In 2020, more than 15,000 fitness professionals attended Optima, and the event won a Gold Stevie Award for Best Educational Conference.

Avid Applauds Its Creative Editing Community for Multiple Emmy Wins and Nominations

Thursday, September 23, 2021 - 6:41pm

BURLINGTON, Mass., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Avid® (Nasdaq: AVID) today congratulates the creative individuals and teams recognized for their outstanding achievements at the 73rd Annual Primetime Creative Arts Emmy® Awards. Presented by the National Academy of Television Arts & Sciences (NATAS), the awards honor the best in primetime television and the backstage crafts that make them possible.

Key Points: 
  • They relied on Avids Media Composer editing software to help create Emmy Award-winning and nominated productions, including A Black Lady Sketch Show, Hacks, The Crown, WandaVision and many more.
  • I cherish editing a show that celebrates kindness and teamwork, and I love being part of Team Avid and their celebration of editors.
  • Avid is extremely proud and congratulates all of our talented customers on their outstanding achievements at this years Emmy Awards and beyond.
  • For more information about Avid solutions and services, visitwww.avid.com, connect with Avid on Facebook , Instagram , Twitter , YouTube , LinkedIn , or subscribe to Avid Blogs .

ChiliSleep Launches a Trio of Online Learning Platforms to Continue Improving How the World Sleeps

Thursday, September 23, 2021 - 2:03pm

Kryo, Inc., the parent company of ChiliSleep, today announced the launch of three sleep learning platforms for both the professional and consumer markets.

Key Points: 
  • Kryo, Inc., the parent company of ChiliSleep, today announced the launch of three sleep learning platforms for both the professional and consumer markets.
  • ChiliSleep has assembled a star-studded roster of health + wellness experts who will share specific strategies to teach people how to get good sleep.
  • One of the featured speakers is Mollie McGlocklin, creator of Sleep Is A Skill and the host of The Sleep Is A Skill Podcast.
  • As the original inventors of the worlds first hydro-powered, temperature-regulated sleep system, ChiliSleep is revolutionizing the way the world sleeps.

Pam Dixon, Executive Director and Founder of World Privacy Forum, Recognized with Electronic Frontier Foundation's Pioneer Award

Thursday, September 23, 2021 - 2:00pm

PORTLAND, Ore., Sept. 23, 2021 /PRNewswire-PRWeb/ -- Pam Dixon, researcher, author and executive director and founder of World Privacy Forum (WPF), has been named a 2021 Pioneer Award recipient by the Electronic Frontier Foundation (EFF).

Key Points: 
  • PORTLAND, Ore., Sept. 23, 2021 /PRNewswire-PRWeb/ -- Pam Dixon, researcher, author and executive director and founder of World Privacy Forum (WPF), has been named a 2021 Pioneer Award recipient by the Electronic Frontier Foundation (EFF).
  • As WPF's executive director, Dixon has worked extensively on privacy and data governance in the U.S., EU, India, Africa and Asia.
  • WPF has published numerous studies that have had a significant impact in the areas of identity, health, finance and AI.
  • Awarded annually since 1992, EFF's Pioneer Awards recognize the leaders who are extending freedom and innovation on the electronic frontier.

Health2047 Launches RecoverX to Empower Physicians with Evidence-Based Augmented Intelligence

Thursday, September 23, 2021 - 1:01pm

Health2047 Inc. , the Silicon Valley-based innovation subsidiary of the American Medical Association (AMA), has both helped shape and invested in RecoverX, a startup that develops evidence-based medicine (EBM) augmented intelligence (AI) technologies to support and enrich physicians decision-making.

Key Points: 
  • Health2047 Inc. , the Silicon Valley-based innovation subsidiary of the American Medical Association (AMA), has both helped shape and invested in RecoverX, a startup that develops evidence-based medicine (EBM) augmented intelligence (AI) technologies to support and enrich physicians decision-making.
  • RecoverX is transforming the way physicians practice, moving from the currently overwhelmed human-based present to an evidence-based, AI-empowered future.
  • RecoverX develops evidence-based augmented intelligence technologies to support and enrich medical decision making.
  • RecoverX is a multi-disciplinary medical, AI and engineering team creating advanced technology for augmented intelligence in medicine.

OncoNano Medicine Announces Expanded Research Collaboration With UT Southwestern Medical Center to Advance Development of New Cancer Therapies

Wednesday, September 22, 2021 - 12:00pm

OncoNano will have an exclusive option to license new technology arising from the research conducted under this agreement.

Key Points: 
  • OncoNano will have an exclusive option to license new technology arising from the research conducted under this agreement.
  • Dr. Gao and his team at UTSW invented the ultra pH-sensitive nanoparticle technology that represents the core of OncoNanos differentiated oncology research platform.
  • We look forward to this research collaboration with OncoNano Medicine to continuously translate lab discoveries into potentially important clinical applications.
  • UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education.

Tenjin and GameAnalytics launch Growth FullStack

Wednesday, September 22, 2021 - 11:00am

SAN FRANCISCO and LONDON, Sept. 22, 2021 /PRNewswire/ -- Tenjin, the leading mobile marketing measurement platform for indie and mid-sized mobile game publishers, and GameAnalytics, the player analysis platform of choice for mobile game developers, have launched Growth FullStack, the first in a new series of developer tools and training resources offering affordable access to data and analyses.

Key Points: 
  • Launched to coincide with the release of iOS15, Growth FullStack empowers mobile developers to navigate a privacy-centric marketing landscape which requires a unified approach to managing significant amounts of disparate datasets.
  • Growth FullStack enables mobile publishers to collect the data that they need, store it in the way they want, and optimize their campaigns activity using off-the-shelf or custom analyses.
  • "We're excited to partner with GameAnalytics to offer Growth FullStack.
  • Ultimately we want to focus our energy on making games, and Growth FullStack will be vital in enabling that."

National Climate Change Forum With Renowned Climate Expert, Physicist, and Top Obama Admin. Scientist Dr. Steven E. Koonin

Tuesday, September 21, 2021 - 2:00pm

WASHINGTON, Sept. 21, 2021 (GLOBE NEWSWIRE) -- On Tuesday, Sept. 28, the National Post will presentan in-depth discussion with leading climate expert Dr. Steven E. Koonin about the current state of globalclimate change and climate policy.

Key Points: 
  • WASHINGTON, Sept. 21, 2021 (GLOBE NEWSWIRE) -- On Tuesday, Sept. 28, the National Post will presentan in-depth discussion with leading climate expert Dr. Steven E. Koonin about the current state of globalclimate change and climate policy.
  • Koonin draws upon his decades of experience to provide up-to-date insights and expert perspective free from political agendas.
  • ABOUT DR. KOONIN: Dr. Steven E. Koonin is a physicist and leader in science policy in the United States.
  • For more information or to schedule an interview with Steve, please contact Elizabeth Aucamp at elizabeth@javelindc.com or (704) 249-1430.

Longeveron Announces Dr. Jorge Ruiz as Speaker for Roundtable Discussion & Presentation at 2021 International Conference for Frailty & Sarcopenia Research

Tuesday, September 21, 2021 - 1:00pm

MIAMI, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced that Jorge Ruiz, M.D., Associate Director for Clinical Affairs at the Geriatric Research, Education and Clinical Center (GRECC), Miami Veterans Affairs Healthcare System, and lead investigator in the trial, will present the results from the trial titled: A Phase 2b, Randomized, Blinded and Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Lomecel-B Infusion in Patients With Aging Frailty (the “Phase 2b trial”) at the 2021 11th Annual International Conference for Frailty & Sarcopenia (ICFSR).

Key Points: 
  • This increase persisted through 270 days (200 million Lomecel-B group change from baseline 47.9 meters; p=0.0115, and p=0.0077 compared to placebo).
  • By comparison, the placebo-treated subjects change from baseline at 180 days and 270 days was 8.0 meters (p=0.5371) and -15.5 meters (p=0.2728), respectively.
  • Aging Frailty is a life-threatening geriatric condition affecting approximately 15% of Americans over the age of 65, or 8.1 million individuals.
  • Despite the pressing need for interventions, there are no FDA-approved therapies that can slow down, reverse, or prevent Aging Frailty.